Latest Asx News

Page 210 of 1405
Panther Metals Ltd has initiated a pro rata non-renounceable entitlement offer to raise approximately $816,745, aiming to fund its key exploration projects in gold and base metals. The offer opens on 12 November 2025 and closes on 21 November 2025, inviting eligible shareholders in Australia, New Zealand, and the UK to participate.
Maxwell Dee
Maxwell Dee
12 Nov 2025
Tartana Minerals has inked a non-binding Letter of Intent with Alt Resources for up to $5 million in non-dilutive financing, structured to align repayments with copper production and prices. This deal aims to optimize existing operations and fund expansion through the Mungana processing plant.
Maxwell Dee
Maxwell Dee
12 Nov 2025
Reward Minerals has signed a binding Letter of Intent to acquire the Copper Lance Project in Newfoundland, a promising volcanogenic massive sulphide deposit with historic high-grade copper and silver results. The company plans to fast-track exploration to unlock value in this underexplored Canadian terrane.
Maxwell Dee
Maxwell Dee
12 Nov 2025
Australian Vintage reports a modest sales dip in FY25 but charts a clear path to cash flow neutrality and growth through innovation and strategic acquisitions.
Victor Sage
Victor Sage
12 Nov 2025
Patronus Resources (ASX – PTN) reveals a robust financial position with $78 million in cash and investments alongside a 2.3 million ounce gold equivalent resource base, underpinning a multi-commodity growth strategy across Western Australia and the Northern Territory.
Maxwell Dee
Maxwell Dee
12 Nov 2025
Sagalio Energy Limited’s shares have been suspended from ASX trading due to compliance concerns, leaving investors in the dark about the company’s next steps.
Maxwell Dee
Maxwell Dee
12 Nov 2025
The FDA's removal of the black box warning on hormone replacement therapies marks a pivotal shift for Mayne Pharma, potentially unlocking new market opportunities and reshaping women’s health treatment.
Victor Sage
Victor Sage
12 Nov 2025
WCM Global Growth Limited reported a robust FY2025 with net profit soaring to $69.5 million and a 31% portfolio return, prompting increased dividends and a successful $76.7 million capital raise.
Claire Turing
Claire Turing
12 Nov 2025
Actinogen Medical’s XanaMIA Phase 2b/3 trial for Alzheimer’s disease has received a positive safety recommendation from its independent Data Monitoring Committee, allowing the study to proceed unchanged. Investors now await the critical efficacy analysis scheduled for January 2026.
Ada Torres
Ada Torres
12 Nov 2025
Venari Minerals has identified six strong multi-element soil anomalies at its Needles Gold Project in Nevada, highlighting significant untested potential for large-scale epithermal gold-silver mineralisation. The company awaits assay results from recent drilling amid a US lab backlog.
Maxwell Dee
Maxwell Dee
12 Nov 2025
Horseshoe Metals reports strong drilling results confirming extensive shallow copper mineralisation at its Horseshoe Lights Project, with Direct Shipping Ore operations set to begin this quarter amid active offtake and funding talks.
Maxwell Dee
Maxwell Dee
12 Nov 2025
Australian Gold and Copper Ltd has completed its acquisition of the Browns Reef tenement package, doubling its South Cobar Project area and setting the stage for a maiden resource estimate at the Evergreen target.
Maxwell Dee
Maxwell Dee
12 Nov 2025